Skip to main content


Fig. 4 | Acta Neuropathologica Communications

Fig. 4

From: Single-nucleus RNA-seq identifies Huntington disease astrocyte states

Fig. 4

Validation of astrocytic activation in HD. a Representative micrograph of GFAP-HTT dual immunohistochemical stain showing increased GFAP immunoreactivity in the HD cingulate cortex compared to control (scale bar = 50um, GFAP in red & HTT in brown). b Representative images showing accumulation in HTT in the neuropil and in astrocytic in two HD cases (yellow arrows - scale bar = 20um). c Quantification of A, showing increased GFAP immunoreactive cell density in the HD cingulate cortex, n = 8 for control and 6 for HD (grade III and IV), P value = 0.012 (one-sided t-Mann-Whitney U test). d Real-time quantitative PCR showing relative expression of GFAP transcript in grade III/IV HD (n = 7 for HD and 6 for control) Delta CT value normalized to B-Actin transcript levels are shown. P value = 0.0154 (one-sided t-test). e Representative fluorescent immunohistochemical stains showing GFAP (red), metallothionein (MT-green), and DAPI stained nuclei (blue) from a representative control and grade IV HD case. There is increased GFAP immune-positive cells in layers V/VI of the HD cingulate cortex, and large proportion of these astrocytes are MT positive, compared to control (scale bar = 60um).60um). f In situ hybridization (RNAscope™) showing probes for MBP (red), GFAP (white), PLP1 (green), and DAPI-stained nuclei (blue). Note the co-localization of GFAP and PLP-1 (white arrows). An MBP positive PLP-1 positive Oligodendrocyte is indicated by the arrow head. (scale bar = 10um)

Back to article page